DEEPAK-Dabur India Ltd

8/7/2019 DEEPAK-Dabur India Ltd

1/22

DaburDabur India Ltd.India Ltd.Presented by:DEEPAKB.COM IInd YearSECTION A

ROLL NO. - 2379


2/22

Dabur India Limited is the world's largest Ayurvedic & NaturalHealth Care Company and one of India's leading Personal & HealthCare Companies with interests in Hair Care , Oral Care , Health Care , Skin Care ,Home Care and Foods . From its humble beginnings in thebylanes of C a lcutt a way back in 1884 as an Ayurvedic medicines

comp any, Dabur Indi a Ltd has come a long w ay tod ay to become a leading consumer products m anuf acturer in Indi a . Over its 125years of existence, the Dabur brand has stood for goodnessthrough a natural lifestyle.

Headquarters:

Dabur India LimitedKaushambi, SahibabadGhaziabad, UPIndia - 201010

Company Profile


3/22

DaburDabur AtAt--aa--GlanceGlancey Dabur India Limited is the fourth l a rgest FMCG Comp any in Indi a and

Dabur h ad a turnover of approxim a tely Rs. 3390.9 Crore FY 09-10)y 3 m ajor str a tegic business units (SBU) - Consumer Care Division (CCD),

Consumer Health Division (CHD) and International Business Division (IBD)y 3 Subsidi a ry Group comp anies - Dabur International , Fem Care Pharma

and new u and 8 step down subsidi a ries: Dabur Nepal Pvt Ltd (Nep a l),Dabur Egypt Ltd (Egypt) , Asian Consumer Care (Bangladesh) , AsianConsumer Care (Pakistan) , African Consumer Care (Nigeri a ), Naturelle LLC(Ras Al Kha imah-UAE), Weikfield International (UAE)and Jaquline Inc.(USA).

y 17 ultra-modern manufacturing units spre ad a round the globey P roducts m a rketed in over 60 countriesy W ide and deep m a rket penetr a tion with 50 C&F agents , more th an 5000

distributors and over 2.8 million ret a il outlets a ll over Indi a

y Dabur India Limited is the fourth l a rgest FMCG Comp any in Indi a andDabur h ad a turnover of approxim a tely Rs. 3390.9 Crore FY 09-10)

y 3 m ajor str a tegic business units (SBU) - Consumer Care Division (CCD), Consumer Health Division (CHD) and International Business Division (IBD)

y 3 Subsidi a ry Group comp anies - Dabur International , Fem Care Pharmaand new u and 8 step down subsidi a ries: Dabur Nepal Pvt Ltd (Nep a l),Dabur Egypt Ltd (Egypt) , Asian Consumer Care (Bangladesh) , AsianConsumer Care (Pakistan) , African Consumer Care (Nigeri a ), Naturelle LLC(Ras Al Kha imah-UAE), Weikfield International (UAE)and Jaquline Inc.(USA).

y 17 ultra-modern manufacturing units spre ad a round the globey P roducts m a rketed in over 60 countriesy W ide and deep m a rket penetr a tion with 50 C&F agents , more th an 5000

distributors and over 2.8 million ret a il outlets a ll over Indi a


4/22

M anufacturing Facilities in India


5/22

Products

HEALTH CARE

PERSONAL CARE

FOODS

HOME CARECONSUMER HEALTH--

OTC

CONSUMER HEALTH--ETHICAL


6/22

1884:Birth of D abur1972:The comp any shifts b ase to delhi from Kolk a ta1986:Registered as P ublic Limited Comp any1994:Listed in BSE1998: P rofession a l te am inducted to run the comp any2000: Crosses Rs 1000 crore turnover

2003:P

ha rm a comp any de-merged to focus on coreFMCG business2004:profit exceeds Rs 100 crore.

Milestones:Milestones:


7/22

2005: acquires B a la ra strengthning or a l ca re &provided entry into Home c a re segments2006:D abur figures in top 10 gre a t pl aces to work2007:d abur r anks Asia s best under a billionenterprises by forbes2008: acquires Fem C a re P ha rm a entering the

ma instre am skin c a re segment


8/22

2009:strong growth momentum continued inspite of economic downturn. 2009 - Dabur Red Toothpaste

joins 'Billion Rupee Brands' clubDabur Red Toothp aste becomes the D abur's ninthBillion Rupee br and. D abur Red Toothp aste crossesthe billion rupee turnover m a rk within five ye a rs of its launch.


9/22

2010:Dabur stock r anked 14 th in Va lue 100 list , a ranking of a ttr actively-priced stocks of firms with re a l ea rnings.

Dabur Aml a Ha ir Oil & Ra l voted as Most Loved FMCG

Brands with highest top-of-the-mind rec a ll.Dabur Ch a irm an Dr An and Burm an amongst Indi a 's MostP owerful CEOs , placed a t No. 41 on the list.Dabur Indi a Ltd ranked as Indi a 's Most Customer Responsive

FMCG Comp any.Dabur Uved a ranked amongst most successful br ands

launched in 2009 Br and Derby .


10/22

TEN YEAR HIGHLIGHTS


11/22

Continued..


12/22

Sales FigureSales FigureY

ear Sales(in crores)2000 9822

2001 1000

2002 1200

2003 12852004 1236

2005 1417

2006 1757

2007 2080

2008 2396

2009 2834

2010 3417


13/22

Net Profit FiguresNet Profit FiguresYear Net Profit(in crores)

2001 78

2002 64

2003 852004 107

2005 156

2006 214

2007 282

2008 333

2009 391

2010 501


14/22

Performance Growth(2009Performance Growth(2009- -2010)2010)

2009(inmillions)

2010(inmillions)

% change

Total

Income

2830 3389.72 19.73%

ProfitBefore Tax

444.84 602.83 35.51%

Profit After Tax

390 502 28.71%

Earning Per Share

5.82 4.52 28.76%


15/22

PEST ANAL Y SIS

Political Stable political government.Restrictions in import policies.

Rise in customs duty on petrol & diesel.Partial withdrawal of stimulus packages.


16/22

Economical Growth in GDPInflation rate

Increase in disposable income.Indian FM CG Recorded 16% Sales Growth in LastFiscal.The F M CG sector is the 4 th largest sector of Indianeconomy with market size of more than 60,000crore.


17/22

Social

Rising rural India.Consumerism.Demography.

T echnological Volatility Research and development intensity Information technology


18/22

STRENGTHS:Century Old Comp any and 125 ye a rs of experience.Established Br andAyurvedic/ herb a l P roduct lineLeader in Herb a l Digestives where the product h as

90% of the m a rket sh a re.Innov a tiveness in P romotions.More th an 5000 distributors and over 2.8 million

ret a il outlets a ll over indi a .Monopoly st a tus in multiple product c a tegories.

SWOT A nalysis:


19/22

WEAKNESS:

P rofit ability is uneven across product line

Online presence is vit a l for success these d ays, and l ack of one is a limit a tion for D abur Indi a .

Dabur Indi a s R&D work is low and insignific ant , which is a major we akness in FMCG as it isconst antly cre a ting new products.

Low penetr a tion in rur a l a re as in food , he a lthsupplements and home c a re c a tegories.


20/22

OPPORTUNITIES:

Extend V a tika brand to new c a tegories like Skin C a reand body w ash segments

Launch sever a l OTC brandsSouthern Indi a Ma rketExploring new geogr aphic a l a re as- loc a l as well as

glob a lOra l Ca re SegmentP ackaged food c a tegory.Incre asing income level will result in f aster revenue

growth.


21/22

THREATS:

Competition in the FMCG sector from wellest ablished n ames

Other fields of medicine- Allop a thic and

Homeop a thic

Ma rkets where Herb a l products a re notrecognized

Foreign products

Kerela -Hub of ayurved a


22/22

Thank YouThank You

DEEPAK-Dabur India Ltd

Documents